Characteristics of pulmonary mucormycosis and the experiences of surgical resection

被引:8
作者
Shao, Weipeng [1 ,2 ]
Zhang, Jun [1 ,2 ]
Ma, Shanwu [1 ,2 ]
Feng, Hongxiang
Zhang, Zhenrong
Liang, Chaoyang
Liu, Deruo [1 ,2 ]
机构
[1] Peking Univ, China Japan Friendship Sch Clin Med, Dept Gen Thorac Surg, 2 Yinghua,East Rd, Beijing 100029, Peoples R China
[2] China Japan Friendship Hosp, 2 Yinghua,East Rd, Beijing 100029, Peoples R China
关键词
Pulmonary mucormycosis (PM); surgery; operation time; blood loss; AMPHOTERICIN-B; TRANSPLANT RECIPIENTS; INVASIVE ZYGOMYCOSIS; ANTIFUNGAL THERAPY; UPDATE; ASPERGILLOSIS; EPIDEMIOLOGY; PATHOGENESIS; MANAGEMENT; DISEASES;
D O I
10.21037/jtd.2019.12.117
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Pulmonary mucormycosis (PM) is a relatively rare but fatal infection. However, detailed surgery data have been lacking. We summarized the characteristics of this rare disease and clarified the experiences of surgical resection Methods: We conducted a single-center retrospective study of seven patients with PM who underwent surgical resection at China-Japan Friendship Hospital from May 2011 to May 2018. Results: Patient ages ranged from 18 to 70 years, with a median age of 47 years. Manual workers (85.7%) were the most common occupation and their educational level was also below high school. Diabetes was the most common underlying condition. The most common radiographic finding was lobar consolidation. Three patients directly underwent open thoracotomy, one patient underwent video-assisted thoracic surgery (VATS) and three patients converted from VATS to thoracotomy. The median operation time was 240 min [interquartile range (IQR), 150-390 min], the median intraoperative blood loss was 500 mt. (IQR, 100-1,200 mL) and the median intraoperative blood transfusion was 600 mL (IQR, 0-1,600 mL). In-hospital, 90-day, 1-year and 5-year mortality were 14.3%, 14.3%, 28.8% and 42.9%, respectively. Conclusions: PM is a rare but fatal infection. Due to chest adhesion and vascular invasion, the proportion of massive bleeding and long operation time has increased sharply.
引用
收藏
页码:733 / 740
页数:8
相关论文
共 34 条
  • [1] Successful Treatment of Invasive Pulmonary Mucormycosis in an Immunocompromised Patient
    Afolayan, Oluwatobi
    Copeland, Hannah
    Hargrove, Rachel
    Zaheer, Salman
    Wallen, Jason M.
    [J]. ANNALS OF THORACIC SURGERY, 2016, 101 (04) : E117 - E119
  • [2] Al-Sheikhli Jaffar, 2018, BMJ Case Rep, V2018, DOI 10.1136/bcr-2017-222792
  • [3] Enhancement of Candida albicans Virulence After Exposition to Cigarette Mainstream Smoke
    Baboni, Fernanda Brasil
    Barp, Dayton
    Santos de Azevedo Izidoro, Ana Claudia
    Samaranayake, Lakshman Perera
    Ribeiro Rosa, Edvaldo Antonio
    [J]. MYCOPATHOLOGIA, 2009, 168 (05) : 227 - 235
  • [4] Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with Hematologic malignancy who have zygomycosis
    Chamilos, Georgios
    Lewis, Russell E.
    Kontoyiannis, Dimitrios P.
    [J]. CLINICAL INFECTIOUS DISEASES, 2008, 47 (04) : 503 - 509
  • [5] Factors affecting surgical resection and treatment outcomes in patients with pulmonary mucormycosis
    Choi, Hayoung
    Lee, Hyun
    Jeon, Kyeongman
    Suh, Gee Young
    Shin, Sumin
    Kim, Hong Kwan
    Kim, Kyunga
    Jeong, Daecheon
    Kim, Hojoong
    [J]. JOURNAL OF THORACIC DISEASE, 2019, 11 (03) : 892 - +
  • [6] CUNNINGHAMELLA INFECTIONS - REVIEW AND REPORT OF 2 CASES OF CUNNINGHAMELLA PNEUMONIA IN IMMUNOCOMPROMISED CHILDREN
    COHENABBO, A
    BOZEMAN, PM
    PATRICK, CC
    [J]. CLINICAL INFECTIOUS DISEASES, 1993, 17 (02) : 173 - 177
  • [7] Successful treatment of pulmonary zygomycosis in two transplant recipients with liposomal amphotericin B and partial surgical resection followed by posaconazole
    Cooke, David T.
    Pagani, Francis D.
    Kaul, Daniel R.
    Cooke, Kenneth R.
    Lau, Christine L.
    Riddell, James
    [J]. MYCOSES, 2010, 53 (02) : 163 - 167
  • [8] Characteristics of pulmonary mucormycosis and predictive risk factors for the outcome
    Feng, Jun
    Sun, Xuefeng
    [J]. INFECTION, 2018, 46 (04) : 503 - 512
  • [9] Fernandez Juan F, 2013, Respir Care, V58, pe60, DOI 10.4187/respcare.02106
  • [10] Zygomycosis (mucormycosis): emerging clinical importance and new treatments
    Greenberg, RN
    Scott, LJ
    Vaughn, HH
    Ribes, JA
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2004, 17 (06) : 517 - 525